Patents by Inventor Matthew Titlow

Matthew Titlow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12697340
    Abstract: Compositions and methods are presented that that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Especially preferred compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions will be effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation.
    Type: Grant
    Filed: November 3, 2021
    Date of Patent: August 4, 2026
    Assignee: JUVN3 HOLDINGS, LLC
    Inventors: Hector L. Lopez, Tim Ziegenfuss, Matthew Titlow
  • Publication number: 20260053767
    Abstract: Orally administered low-dose formulations for medium chain di-carboxylic acids have unexpectedly a numerous of beneficial cytoprotective effects in a variety of cells. In particular, contemplated formulations compositions and methods reduce, reverse, and/or prevent liver inflammation, hepatic steatosis, and/or liver fibrosis in NASH, improve blood glucose control, and provide additional cytoprotective benefits such as stimulation of mitochondrial biogenesis, increased SIRT and NAMPT levels, increased NAD+, antioxidant capacity, and/or reduction of DNA damage.
    Type: Application
    Filed: May 8, 2023
    Publication date: February 26, 2026
    Applicant: Jemyll, Ltd.
    Inventors: Giulia Angelini, Matthew Titlow, Timothy Shawn Avila
  • Publication number: 20260034137
    Abstract: Compositions and methods are presented that that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Especially preferred compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions will be effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation.
    Type: Application
    Filed: July 1, 2025
    Publication date: February 5, 2026
    Applicant: JUVN3 Holdings, LLC
    Inventors: Hector L. Lopez, Tim Ziegenfuss, Matthew Titlow
  • Publication number: 20250381214
    Abstract: An autobiotic composition includes a prebiotic component and postbiotic component. The prebiotic component is a substance resistant to digestion in the stomach and small intestine and selectively fermentable by microorganisms in the large intestine. The postbiotic component is a short-chain fatty acid, such as butyric acid, lactic acid, succinic acid, or salt or ester thereof, such as tributyrin. An autobiotic composition beneficially combines the microbiome-enhancing effects of a prebiotic with the intestinal healing effects of a postbiotic to provide overall benefits to digestive health. A seedbiotic component may form part of or be co-administered with the autobiotic composition. Enzymes may form part of or be co-administered with the autobiotic composition to enhance digestion of the prebiotic in the stomach and intestine and/or increase microbiome health. An exogenous ketone body component may form part of or be co-administered with the autobiotic composition.
    Type: Application
    Filed: September 3, 2025
    Publication date: December 18, 2025
    Inventors: Gary Millet, Matthew Titlow
  • Patent number: 12472200
    Abstract: An autobiotic composition includes a prebiotic component and postbiotic component. The prebiotic component is a substance resistant to digestion in the stomach and small intestine and selectively fermentable by microorganisms in the large intestine. The postbiotic component is a short-chain fatty acid, such as butyric acid, lactic acid, succinic acid, or salt or ester thereof, such as tributyrin. An autobiotic composition beneficially combines the microbiome-enhancing effects of a prebiotic with the intestinal healing effects of a postbiotic to provide overall benefits to digestive health. A seedbiotic component may form part of or be co-administered with the autobiotic composition. Enzymes may form part of or be co-administered with the autobiotic composition to enhance digestion of the prebiotic in the stomach and intestine and/or increase microbiome health. An exogenous ketone body component may form part of or be co-administered with the autobiotic composition.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: November 18, 2025
    Assignees: AXCESS GLOBAL SCIENCES, LLC
    Inventors: Gary Millet, Matthew Titlow
  • Patent number: 12433912
    Abstract: A method of administering an autobiotic composition that includes a prebiotic component and postbiotic component. The prebiotic component is a substance resistant to digestion in the stomach and small intestine and selectively fermentable by microorganisms in the large intestine. The postbiotic component is a short-chain fatty acid, such as butyric acid, lactic acid, succinic acid, or salt or ester thereof. The prebiotic component is advantageously delivered to the stomach and/or small intestine and the postbiotic is advantageously delivered to the large intestine. A seedbiotic component may form part of or be co-administered with the autobiotic composition. Enzymes may form part of or be co-administered with the autobiotic composition to enhance digestion of the prebiotic in the stomach and intestine and/or increase microbiome health. An exogenous ketone body component may form part of or be co-administered with the autobiotic composition.
    Type: Grant
    Filed: August 26, 2024
    Date of Patent: October 7, 2025
    Assignee: AXCESS GLOBAL SCIENCES, LLC
    Inventors: Gary Millet, Matthew Titlow
  • Publication number: 20240415870
    Abstract: A method of administering an autobiotic composition that includes a prebiotic component and postbiotic component. The prebiotic component is a substance resistant to digestion in the stomach and small intestine and selectively fermentable by microorganisms in the large intestine. The postbiotic component is a short-chain fatty acid, such as butyric acid, lactic acid, succinic acid, or salt or ester thereof. The prebiotic component is advantageously delivered to the stomach and/or small intestine and the postbiotic is advantageously delivered to the large intestine. A seedbiotic component may form part of or be co-administered with the autobiotic composition. Enzymes may form part of or be co-administered with the autobiotic composition to enhance digestion of the prebiotic in the stomach and intestine and/or increase microbiome health. An exogenous ketone body component may form part of or be co-administered with the autobiotic composition.
    Type: Application
    Filed: August 26, 2024
    Publication date: December 19, 2024
    Inventors: Gary MILLET, Matthew TITLOW
  • Patent number: 11925645
    Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.
    Type: Grant
    Filed: February 21, 2023
    Date of Patent: March 12, 2024
    Assignee: ORTHO-NUTRA, LLC
    Inventors: Hector L. Lopez, Tim N. Ziegenfuss, Matthew Titlow
  • Publication number: 20230263746
    Abstract: Compositions and methods are provided to increase the healthspan of a subject. Most typically, contemplated compositions are formulated for oral administration and comprise a synergistic combination of a first and a second polyamine (e.g., spermine and spermidine).
    Type: Application
    Filed: February 23, 2023
    Publication date: August 24, 2023
    Applicant: Compound Solutions Inc.
    Inventor: Matthew Titlow
  • Publication number: 20230219881
    Abstract: A simplified synthetic process for production of spermine and spermidine are presented that can provide spermine and spermidine in free base or salt form. Advantageously, the synthetic procedure is safe, simple, and environmentally friendly, while at the same time also being cost-effective.
    Type: Application
    Filed: December 20, 2022
    Publication date: July 13, 2023
    Applicants: Compound Solutions Inc., Shaoxing King-Year Biochemical Co., Ltd.
    Inventors: Matthew Titlow, Xinglong Gu
  • Publication number: 20230190757
    Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.
    Type: Application
    Filed: February 21, 2023
    Publication date: June 22, 2023
    Applicant: Ortho-Nutra, LLC
    Inventors: Hector L. Lopez, Tim N. Ziegenfuss, Matthew Titlow
  • Publication number: 20230149488
    Abstract: Compositions and methods are presented that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Especially preferred compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions will be effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation.
    Type: Application
    Filed: December 17, 2019
    Publication date: May 18, 2023
    Applicants: JUVN3 Holdings, LLC, JUVN3 Holdings, LLC
    Inventors: Hector L. Lopez, Tim Ziegenfuss, Matthew Titlow
  • Publication number: 20230149412
    Abstract: Compositions and methods are presented that that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Especially preferred compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions will be effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation.
    Type: Application
    Filed: November 3, 2021
    Publication date: May 18, 2023
    Applicant: JUVN3 Holdings, LLC
    Inventors: Hector L. Lopez, Tim Ziegenfuss, Matthew Titlow
  • Patent number: 11583534
    Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: February 21, 2023
    Assignee: Ortho-Nutra, LLC
    Inventors: Hector L Lopez, Tim N. Ziegenfuss, Matthew Titlow
  • Publication number: 20230025435
    Abstract: Compositions and methods are presented that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Exemplary compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, a metal-containing antioxidant, and optionally an additional ingredient, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions are effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation. More specifically, the contemplated compositions are capable of increasing cellular vitality by inducing expression of OCT4, SOX, and/or KLF4 and/or decreasing biomarkers of cell senescence.
    Type: Application
    Filed: January 6, 2021
    Publication date: January 26, 2023
    Applicant: JUVN3 Holdings, LLC
    Inventors: Tim N. Ziegenfuss, Matthew Titlow, Hector L. Lopez
  • Patent number: 11141442
    Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: October 12, 2021
    Assignee: Compound Solutions, Inc.
    Inventor: Matthew Titlow
  • Patent number: 11045509
    Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: June 29, 2021
    Assignee: COMPOUND SOLUTIONS, INC.
    Inventor: Matthew Titlow
  • Publication number: 20210137928
    Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.
    Type: Application
    Filed: October 30, 2020
    Publication date: May 13, 2021
    Applicant: Ortho-Nutra, LLC
    Inventors: Hector L Lopez, Tim N. Ziegenfuss, Matthew Titlow
  • Publication number: 20200384042
    Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.
    Type: Application
    Filed: June 6, 2019
    Publication date: December 10, 2020
    Inventor: Matthew Titlow
  • Publication number: 20200384043
    Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.
    Type: Application
    Filed: July 23, 2019
    Publication date: December 10, 2020
    Inventor: Matthew Titlow